The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations
- 1 March 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 6 (2) , 197-219
Abstract
Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the obstructive ...Keywords
This publication has 88 references indexed in Scilit:
- Azithromycin and the Risk of Cardiovascular DeathNew England Journal of Medicine, 2012
- Vaccines Against Drug AbuseClinical Pharmacology & Therapeutics, 2011
- Azithromycin for Prevention of Exacerbations of COPDNew England Journal of Medicine, 2011
- Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma2011
- Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled AsthmaNew England Journal of Medicine, 2010
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Mortality in COPD: Inevitable or Preventable? Insights from the Cardiovascular ArenaCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2008
- Asthma cases attributable to atopy: Results from the Third National Health and Nutrition Examination SurveyJournal of Allergy and Clinical Immunology, 2007
- Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary diseaseBritish Journal of Clinical Pharmacology, 2007
- The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trialJournal of Allergy and Clinical Immunology, 2007